StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30986% above fair value
$32.13−0.03 (-0.09%)

Close on Nov 19, 2026Market cap $1.20BP/E –Yield –

Harrow gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Harrow's gross profit for the twelve months ending Jun 30, 2026 was $201.96M, up 19.0% year over year. For fiscal 2025 it was $204.37M, up 35.9% from the year before. Over ten years it grew 46.4% a year on average. The highest annual figure on record is $204.37M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$204.37M+35.9%
FY2024Dec 31, 2024$150.37M+66.1%
FY2023Dec 31, 2023$90.55M+43.3%
FY2022Dec 31, 2022$63.21M+16.5%
FY2021Dec 31, 2021$54.26M+57.7%
FY2020Dec 31, 2020$34.41M-0.0%
FY2019Dec 31, 2019$34.42M+38.5%
FY2018Dec 31, 2018$24.85M+87.3%
FY2017Dec 31, 2017$13.27M+31.2%
FY2016Dec 31, 2016$10.11M+124.2%
FY2015Dec 31, 2015$4.51M+695.4%
FY2014Dec 31, 2014$567.00K+5570.0%
FY2013Dec 31, 2013$10.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$50.36M+6.0%
Q1 FY2026Mar 31, 2026$27.05M-16.3%
Q4 FY2025Dec 31, 2025$70.62M+34.0%
Q3 FY2025Sep 30, 2025$53.93M+44.8%
Q2 FY2025Jun 30, 2025$47.51M+30.5%
Q1 FY2025Mar 31, 2025$32.31M+34.4%
Q4 FY2024Dec 31, 2024$52.70M+110.3%
Q3 FY2024Sep 30, 2024$37.24M+53.9%
Q2 FY2024Jun 30, 2024$36.40M+55.1%
Q1 FY2024Mar 31, 2024$24.03M+34.8%
Q4 FY2023Dec 31, 2023$25.05M+76.9%
Q3 FY2023Sep 30, 2023$24.20M+50.3%
Q2 FY2023Jun 30, 2023$23.47M+39.8%
Q1 FY2023Mar 31, 2023$17.83M+10.4%
Q4 FY2022Dec 31, 2022$14.16M-6.2%
Q3 FY2022Sep 30, 2022$16.10M+17.0%
Q2 FY2022Jun 30, 2022$16.79M+22.4%
Q1 FY2022Mar 31, 2022$16.16M+38.4%
Q4 FY2021Dec 31, 2021$15.11M+41.8%
Q3 FY2021Sep 30, 2021$13.76M+28.6%
Q2 FY2021Jun 30, 2021$13.72M+182.5%
Q1 FY2021Mar 31, 2021$11.67M+42.5%
Q4 FY2020Dec 31, 2020$10.66M+17.9%
Q3 FY2020Sep 30, 2020$10.70M+23.1%
Q2 FY2020Jun 30, 2020$4.86M-41.4%
Q1 FY2020Mar 31, 2020$8.19M-2.4%
Q4 FY2019Dec 31, 2019$9.04M+24.1%
Q3 FY2019Sep 30, 2019$8.69M+32.8%
Q2 FY2019Jun 30, 2019$8.29M+33.1%
Q1 FY2019Mar 31, 2019$8.39M+75.1%
Q4 FY2018Dec 31, 2018$7.28M+87.7%
Q3 FY2018Sep 30, 2018$6.55M+112.6%
Q2 FY2018Jun 30, 2018$6.23M+74.5%
Q1 FY2018Mar 31, 2018$4.79M+75.0%
Q4 FY2017Dec 31, 2017$3.88M+42.5%
Q3 FY2017Sep 30, 2017$3.08M+22.1%
Q2 FY2017Jun 30, 2017$3.57M–
Q1 FY2017Mar 31, 2017$2.74M–
Q4 FY2016Dec 31, 2016$2.72M–
Q3 FY2016Sep 30, 2016$2.52M–

More Harrow figures

See a number that looks wrong?